DURVALUMAB
Clinical trials for DURVALUMAB explained in plain language.
Never miss a new study
Get alerted when new DURVALUMAB trials appear
Sign up with your email to follow new studies for DURVALUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for tough liver cancer cases
Disease control Recruiting nowThis study tests a new treatment for people with advanced liver cancer that cannot be removed by surgery. It combines precise proton radiation with two immunotherapy drugs (tremelimumab and durvalumab) to boost the immune system's attack on tumors. About 45 participants will rece…
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New triple therapy shows promise for hard-to-treat bile duct cancer
Disease control Recruiting nowThis study tests a new first-line treatment for people with advanced bile duct cancer that cannot be removed by surgery. The treatment combines chemotherapy delivered directly to the liver (HAIC) with two drugs: durvalumab (an immunotherapy) and lenvatinib (a targeted therapy). T…
Matched conditions: DURVALUMAB
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 11, 2026 20:38 UTC